Formulation and Drug Delivery, Topical Drugs

October 12th 2023

The draft guidance document discusses quality considerations for topical ophthalmic drug products.

July 3rd 2023

FDA’s new guidance on in-vitro permeation test studies published in October 2022 gives technical and statistical requirements for conducting these tests to compare topical generic drugs with their reference products.

February 3rd 2023

Topical eye treatments can be beneficial for patients with a growing array of eye diseases, but only if taken appropriately.

November 1st 2022

Gerresheimer has developed a new dropper insert for ophthalmic formulations that it is showcasing at CPHI 2022 in Frankfurt, Germany.